RedHill Biopharma (RDHL) Reports Q4 Operating Loss of $20.7M
Tweet
Share
E-mailGet Alerts RDHL Hot Sheet
Join SI Premium – FREE
RedHill Biopharma (NASDAQ: RDHL) reported Q4 operating loss of $20.7 million. Revenue for the quarter came in at $22.1 million versus the consensus estimate of $24.08 million.
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Webull Corp (BULL) Tops Q2 EPS by 1c
- TJX stock drops as profit outlook falls short of analyst estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
